Shortened-Duration Tacrolimus after Nonmyeloablative HLA-Haploidentical (NMA haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Facilitates Strategies for Relapse Reduction

被引：3

作者：

Kasamon, Yvette L. ^{[1
]}

Fuchs, Ephraim J. ^{[1
]}

Zahurak, Marianna ^{[1
]}

Rosner, Gary L. ^{[1
]}

Symons, Heather J. ^{[1
]}

Bolanos-Meade, Javier ^{[1
]}

Jones, Richard J. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Baltimore, MD USA

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.831.831

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

831

引用

页数：5

共 23 条

[1] Nonmyeloablative HLA-Haploidentical (NMA Haplo) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Is Associated with Similar Outcomes to Matched BMT When Stratified By Disease Risk Index (DRI)
McCurdy, Shannon R.
Kanakry, Jennifer A.
Showel, Margaret M.
Tsai, Hua-Ling
Bolanos-Meade, Javier
Kanakry, Christopher G.
Gladstone, Douglas E.
Luznik, Leo
Huff, Carol Ann
Swinnen, Lode J.
Ambinder, Richard F.
Jones, Richard J.
Fuchs, Ephraim J.
Kasamon, Yvette L.
[J]. BLOOD, 2014, 124 (21)
[2] Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation
Kasamon, Yvette L.
Fuchs, Ephraim J.
Zahurak, Marianna
Rosner, Gary L.
Symons, Heather J.
Gladstone, Douglas E.
Huff, Carol Ann
Swinnen, Lode J.
Brodsky, Robert A.
Matsui, William H.
Borrello, Ivan
Shanbhag, Satish
Cooke, Kenneth R.
Ambinder, Richard F.
Luznik, Leo
Bolanos-Meade, Javier
Jones, Richard J.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (05) : 1022 - 1028
[3] Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
McCurdy, Shannon R.
Kanakry, Jennifer A.
Showel, Margaret M.
Tsai, Hua-Ling
Bolanos-Meade, Javier
Rosner, Gary L.
Kanakry, Christopher G.
Perica, Karlo
Symons, Heather J.
Brodsky, Robert A.
Gladstone, Douglas E.
Huff, Carol Ann
Pratz, Keith W.
Prince, Gabrielle T.
Dezern, Amy E.
Gojo, Ivana
Matsui, William H.
Borrello, Ivan
McDevitt, Michael A.
Swinnen, Lode J.
Smith, B. Douglas
Levis, Mark J.
Ambinder, Richard F.
Luznik, Leo
Jones, Richard J.
Fuchs, Ephraim J.
Kasamon, Yvette L.
[J]. BLOOD, 2015, 125 (19) : 3024 - 3031
[4] Significance of Missing Inhibitory KIR Ligands in Nonmyeloablative, HLA-Haploidentical (Haplo) BMT with Posttransplantation High-Dose Cyclophosphamide (PT/Cy)
Kasamon, Yvette L.
Luznik, Leo
Leffell, M. Sue
Tsai, Hua-ling
Symons, Heather J.
Bolanos-Meade, Javier
Rosner, Gary
Morris, Lawrence E.
Crilley, Pamela A.
Jones, Richard J.
Fuchs, Ephraim J.
[J]. BLOOD, 2011, 118 (21) : 383 - 384
[5] SIGNIFICANCE OF HAPLOTYPE B DONORS AND GENE CONTENT MOTIFS IN NONMYELOABLATIVE, HLA-HAPLOIDENTICAL (Haplo) BMT WITH POSTTRANSPLANTATION HIGH-DOSE CYCLOPHOSPHAMIDE (PT/Cy)
Symons, H. J.
Munchel, A. T.
Rossiter, N. L.
Kasamon, Y. L.
Jones, R. J.
Fuchs, E. J.
Leffell, M. S.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S218 - S218
[6] Nonmyeloablative (NMA), HLA-Mismatched Unrelated Donor (mMUD) BMT with High-Dose Posttransplantation Cyclophosphamide (PTCy) Has Outcomes Similar to Matched BMT
Kasamon, Yvette L.
Fuchs, Ephraim J.
Bolanos-Meade, Javier
Leffell, Mary S.
Zahurak, Marianna
Rosner, Gary L.
Powell, Jonathan D.
Ambinder, Richard F.
Jones, Richard J.
Luznik, Leo
[J]. BLOOD, 2015, 126 (23)
[7] Nonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome
Kasamon, Yvette L.
Luznik, Leo
Leffell, Mary S.
Kowalski, Jeanne
Tsai, Hua-Ling
Bolanos-Meade, Javier
Morris, Lawrence E.
Crilley, Pamela A.
O'Donnell, Paul V.
Rossiter, Nancy
Huff, Carol Ann
Brodsky, Robert A.
Matsui, William H.
Swinnen, Lode J.
Borrello, Ivan
Powell, Jonathan D.
Ambinder, Richard F.
Jones, Richard J.
Fuchs, Ephraim J.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (04) : 482 - 489
[8] HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Luznik, Leo
O'Donnell, Paul V.
Symons, Heather J.
Chen, Allen R.
Leffell, M. Susan
Zahurak, Marianna
Gooley, Ted A.
Piantadosi, Steve
Kaup, Michele
Ambinder, Richard F.
Huff, Carol Ann
Matsui, William
Bolanos-Meade, Javier
Borrello, Ivan
Powell, Jonathan D.
Harrington, Elizabeth
Warnock, Sandy
Flowers, May
Brodsky, Robert A.
Sandmaier, Brenda M.
Storb, Rainer F.
Jones, Richard J.
Fuchs, Ephraim J.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (06) : 641 - 650
[9] Shortened-Duration Immunosuppressive Therapy after Nonmyeloablative, Related HLA-Haploidentical or Unrelated Peripheral Blood Grafts and Post-Transplantation Cyclophosphamide
DeZern, Amy E.
Elmariah, Hany
Zahurak, Marianna
Rosner, Gary L.
Gladstone, Douglas E.
Ali, Syed Abbas
Huff, Carol Ann
Swinnen, Lode J.
Imus, Phil
Borrello, Ivan
Wagner-Johnston, Nina D.
Ambinder, Richard F.
Brodsky, Robert A.
Cooke, Kenneth
Luznik, Leo
Fuchs, Ephraim J.
Bolanos-Meade, Javier
Jones, Richard J.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (11) : 2075 - 2081
[10] NONMYELOABLATIVE HLA-HAPLOIDENTICAL BONE MARROW TRANSPLANTATION (HAPLO-BMT) WITH POST-TRANSPLANT HIGH-DOSE CYCLOPHOSPHAMIDE (CY) IN PATIENTS WITH SEVERE HEMOGLOBINOPATHIES
Bolanos-Meade, J.
Lanzkron, S.
Kemberling, H.
Gamper, C.
Ambinder, R. F.
Luznik, L.
Luznik, E. J.
Jones, R. J.
Brodsky, R. A.
[J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S285 - S285

← 1 2 3 →